Hypochlorous acid-activated two-photon fluorescent probe for evaluation of anticancer drugs-induced cardiotoxicity and screening of antioxidant drugs

Kaiqiang Liu,Jian Zhang,Xinxin Li,Yingying Xie,Yong Li,Xu Wang,Xiaoyun Jiao,Xilei Xie,Bo Tang,Kaiqing Liu
DOI: https://doi.org/10.1039/d2qo01408d
IF: 5.456
2022-10-06
Organic Chemistry Frontiers
Abstract:While the widespread use of chemotherapy has greatly improved the survival rate of cancer patients, the immense suffering derived from the significant toxic side effects also has been accompanied. Since the cardiotoxicity caused by anticancer drugs seriously affects the prognosis and life quality of cancer patients, it is crucial to monitor the early stage of cardiotoxicity and myocardial damage induced by chemotherapy drugs timely. However, the traditional diagnostic methods have several deficiencies including the lack of specificity and the delayed detection results. Herein we developed a lysosomal targeted two-photon fluorescent probe THPIC for the real-time tracking of endogenous HClO specifically. THPIC has been employed as an imaging and diagnostic tool to verify that the administration of different anticancer drugs could lead to the elevation of HClO with varying degrees in H9C2 cells and the corresponding heart tissue sections, which would be prevented by the pre-treatment of conventional antioxidant drugs. Moreover, the results of H&E staining and Western Blot assay showed that the up-regulated HClO could induce the activation of TNF-α through oxidative stress and then cause cardiotoxicity and myocardial injury. Antioxidant drugs could protect the heart by depleting elevated ROS to maintain a normal redox balance in H9C2 cells. Therefore, HClO could be regarded as a biomarker for evaluating cardiotoxicity induced by anticancer drugs, and THPIC could be applied as a platform for screening drugs to prevent cardiotoxicity.
chemistry, organic
What problem does this paper attempt to address?